Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,197
archived clinical trials in
Atrial Fibrillation

Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
Johns Hopkins
mi
from
Baltimore, MD
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
Massachusetts General Hospital
mi
from
Boston, MA
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
Beaumont Hospital
mi
from
Royal Oak, MI
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
Mayo Clinic Rochester/St. Mary's Hospital
mi
from
Rochester, MN
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
Mayo Clinic Rochester/St. Mary's Hospital
mi
from
Rochester, MN
Click here to add this to my saved trials
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
Duke University
mi
from
Durham, NC
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
Medical University of South Carolina
mi
from
Charleston, SC
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
Texas Cardiac Arrhythmia Research Foundation
mi
from
Austin, TX
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
Texas Cardiac Arrhythmia Research Foundation
mi
from
Austin, TX
Click here to add this to my saved trials
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
Intermountain Medical Center
mi
from
Murray, UT
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
University of Virginia Health System
mi
from
Charlottesville, VA
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
Sentara Cardiovascular Research Institute
mi
from
Norfolk, VA
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
Sentara Cardiovascular Research Institute
mi
from
Norfolk, VA
Click here to add this to my saved trials
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
University of Alabama at Birmingham
mi
from
Birminham, AL
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
University of Alabama at Birmingham
mi
from
Birminham, AL
Click here to add this to my saved trials
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
UCSF
mi
from
San Francisco, CA
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
Mt. Sinai Hospital
mi
from
NY, NY
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
Mt. Sinai Hospital
mi
from
NY, NY
Click here to add this to my saved trials
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated:  7/30/2015
Methodist Hospital
mi
from
Houston, TX
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) (HeartLight) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Status: Enrolling
Updated: 7/30/2015
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
PREMIUM Registry: PRognostic HEModynamIc Profiling in the AcUtely Ill EMergency Department Patient
PROGNOSTIC HEMODYNAMIC PROFILING IN THE ACUTELY ILL EMERGENCY DEPARTMENT PATIENT
Status: Enrolling
Updated:  8/3/2015
Detroit Receiving Hospital/Wayne State University
mi
from
Detroit, MI
PREMIUM Registry: PRognostic HEModynamIc Profiling in the AcUtely Ill EMergency Department Patient
PROGNOSTIC HEMODYNAMIC PROFILING IN THE ACUTELY ILL EMERGENCY DEPARTMENT PATIENT
Status: Enrolling
Updated: 8/3/2015
Detroit Receiving Hospital/Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
PREMIUM Registry: PRognostic HEModynamIc Profiling in the AcUtely Ill EMergency Department Patient
PROGNOSTIC HEMODYNAMIC PROFILING IN THE ACUTELY ILL EMERGENCY DEPARTMENT PATIENT
Status: Enrolling
Updated:  8/3/2015
Henry Ford Hospital
mi
from
Detroit, MI
PREMIUM Registry: PRognostic HEModynamIc Profiling in the AcUtely Ill EMergency Department Patient
PROGNOSTIC HEMODYNAMIC PROFILING IN THE ACUTELY ILL EMERGENCY DEPARTMENT PATIENT
Status: Enrolling
Updated: 8/3/2015
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
PREMIUM Registry: PRognostic HEModynamIc Profiling in the AcUtely Ill EMergency Department Patient
PROGNOSTIC HEMODYNAMIC PROFILING IN THE ACUTELY ILL EMERGENCY DEPARTMENT PATIENT
Status: Enrolling
Updated:  8/3/2015
University LaSapienza Rome Sant'Andrea Hospital
mi
from
Rome,
PREMIUM Registry: PRognostic HEModynamIc Profiling in the AcUtely Ill EMergency Department Patient
PROGNOSTIC HEMODYNAMIC PROFILING IN THE ACUTELY ILL EMERGENCY DEPARTMENT PATIENT
Status: Enrolling
Updated: 8/3/2015
University LaSapienza Rome Sant'Andrea Hospital
mi
from
Rome,
Click here to add this to my saved trials
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated:  8/13/2015
Mobile Infirmary Medical Center
mi
from
Mobile, AL
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated: 8/13/2015
Mobile Infirmary Medical Center
mi
from
Mobile, AL
Click here to add this to my saved trials
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated:  8/13/2015
Providence Hospital,
mi
from
Mobile, AL
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated: 8/13/2015
Providence Hospital,
mi
from
Mobile, AL
Click here to add this to my saved trials
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated:  8/13/2015
Saint Agnes Medical Center
mi
from
Fresno, CA
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated: 8/13/2015
Saint Agnes Medical Center
mi
from
Fresno, CA
Click here to add this to my saved trials
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated:  8/13/2015
Advocate Christ Medical Center
mi
from
Oak Lawn, IL
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated: 8/13/2015
Advocate Christ Medical Center
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated:  8/13/2015
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated: 8/13/2015
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated:  8/13/2015
Baptist Memorial Hospital
mi
from
Memphis, TN
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated: 8/13/2015
Baptist Memorial Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated:  8/13/2015
Swedish Medical Center
mi
from
Seattle, WA
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated: 8/13/2015
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated:  8/13/2015
Trinity Medical Center
mi
from
Birmingham, AL
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated: 8/13/2015
Trinity Medical Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated:  8/13/2015
Southeast Alabama Medical Center
mi
from
Dothan, AL
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated: 8/13/2015
Southeast Alabama Medical Center
mi
from
Dothan, AL
Click here to add this to my saved trials
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated:  8/13/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated: 8/13/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated:  8/13/2015
St. Vincents Hospital
mi
from
Jacksonville, FL
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated: 8/13/2015
St. Vincents Hospital
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated:  8/13/2015
Florida Hospital
mi
from
Orlando, FL
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated: 8/13/2015
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated:  8/13/2015
Saint Francis Heart Center
mi
from
Indianapolis, IN
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated: 8/13/2015
Saint Francis Heart Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated:  8/13/2015
ST. Luke's Hospital
mi
from
Kansas City, MO
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated: 8/13/2015
ST. Luke's Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated:  8/13/2015
Columbia University Medical Center
mi
from
New York, NY
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated: 8/13/2015
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated:  8/13/2015
Ohio State University Medical Center
mi
from
Columbus, OH
Evaluation Of New Onset Postoperative Atrial Fibrillation
Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM® for Pericardial Closure
Status: Enrolling
Updated: 8/13/2015
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Relationship Between Autonomic Central Nervous System Activation and Atrial Fibrillation Using Functional MRI (fMRI)
Relationship Between Autonomic Central Nervous System Activation and Atrial Fibrillation: A Prospective Functional MRI Study (fMRI)
Status: Enrolling
Updated:  8/13/2015
University of Utah
mi
from
Salt Lake City, UT
Relationship Between Autonomic Central Nervous System Activation and Atrial Fibrillation Using Functional MRI (fMRI)
Relationship Between Autonomic Central Nervous System Activation and Atrial Fibrillation: A Prospective Functional MRI Study (fMRI)
Status: Enrolling
Updated: 8/13/2015
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation
Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation Rates in Post-Operative Cardiac Surgery Patients
Status: Enrolling
Updated:  8/18/2015
Staten Island University Hosptial
mi
from
Staten Island, NY
Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation
Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation Rates in Post-Operative Cardiac Surgery Patients
Status: Enrolling
Updated: 8/18/2015
Staten Island University Hosptial
mi
from
Staten Island, NY
Click here to add this to my saved trials
Stroke Feasibility Study
Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated
Status: Enrolling
Updated:  8/24/2015
St. Helena Hospital
mi
from
St. Helena, CA
Stroke Feasibility Study
Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated
Status: Enrolling
Updated: 8/24/2015
St. Helena Hospital
mi
from
St. Helena, CA
Click here to add this to my saved trials
Stroke Feasibility Study
Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated
Status: Enrolling
Updated:  8/24/2015
Mercy Hospital
mi
from
Miami, FL
Stroke Feasibility Study
Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated
Status: Enrolling
Updated: 8/24/2015
Mercy Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Stroke Feasibility Study
Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated
Status: Enrolling
Updated:  8/24/2015
Franciscan St. Francis Health, Site
mi
from
Indianapolis, IN
Stroke Feasibility Study
Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated
Status: Enrolling
Updated: 8/24/2015
Franciscan St. Francis Health, Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Stroke Feasibility Study
Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated
Status: Enrolling
Updated:  8/24/2015
Good Samaritan Hospital
mi
from
Cincinnati, OH
Stroke Feasibility Study
Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated
Status: Enrolling
Updated: 8/24/2015
Good Samaritan Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Stroke Feasibility Study
Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated
Status: Enrolling
Updated:  8/24/2015
Houston Methodist Hospital
mi
from
Houston, TX
Stroke Feasibility Study
Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated
Status: Enrolling
Updated: 8/24/2015
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Stroke Feasibility Study
Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated
Status: Enrolling
Updated:  8/24/2015
University of Virginia
mi
from
Charlottesville, VA
Stroke Feasibility Study
Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated
Status: Enrolling
Updated: 8/24/2015
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Stroke Feasibility Study
Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated
Status: Enrolling
Updated:  8/24/2015
Aspirus
mi
from
Wausau, WI
Stroke Feasibility Study
Feasibility Clinical Investigation of a Minimally Invasive Surgically Deployed AtriCure AtriClip Left Atrial Appendage Exclusion System for Stroke Prophylaxis in Patients With Non-Valvular Atrial Fibrillation and in Whom Long Term Oral Anticoagulation Therapy is Medically Contraindicated
Status: Enrolling
Updated: 8/24/2015
Aspirus
mi
from
Wausau, WI
Click here to add this to my saved trials
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Status: Enrolling
Updated:  8/27/2015
Veterans' Affairs Medical Center
mi
from
Birmingham, AL
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Status: Enrolling
Updated: 8/27/2015
Veterans' Affairs Medical Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Status: Enrolling
Updated:  8/27/2015
Cardiovascular Consultants - Thunderbird
mi
from
Glendale, AZ
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Status: Enrolling
Updated: 8/27/2015
Cardiovascular Consultants - Thunderbird
mi
from
Glendale, AZ
Click here to add this to my saved trials
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Status: Enrolling
Updated:  8/27/2015
Cardiovascular Consultants - Phoenix
mi
from
Phoenix, AZ
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Status: Enrolling
Updated: 8/27/2015
Cardiovascular Consultants - Phoenix
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Status: Enrolling
Updated:  8/27/2015
Orthoarkansas
mi
from
Little Rock, AR
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Status: Enrolling
Updated: 8/27/2015
Orthoarkansas
mi
from
Little Rock, AR
Click here to add this to my saved trials
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Status: Enrolling
Updated:  8/27/2015
Comprehensive Cardiovascular Specialists
mi
from
Alhambra, CA
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Status: Enrolling
Updated: 8/27/2015
Comprehensive Cardiovascular Specialists
mi
from
Alhambra, CA
Click here to add this to my saved trials